A research team at the University of Wisconsin-Madison produced high-resolution images of RSV structure, important for RSV ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

RSV season is upon us, which means thousands of children under five years of age and hundreds of thousands of adults will be ...

Respiratory syncytial virus and influenza activity are on the rise in parts of the country, particularly among young children, according to the CDC's latest respiratory virus updates. Overall, the ...

It’s called respiratory syncytial virus (RSV), and while it’s usually not super serious in older kids and healthy young adults, it can be really risky for babies and older people. According to ...

Nov. 7—(StatePoint) Each year, as many as 80,000 children younger than 5 are hospitalized due to respiratory syncytial virus (RSV) in the United States. RSV is the leading cause of hospitalization in ...

Researchers sought to determine if the RSV vaccine leads to better health outcomes among older adults with IBD.

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...

Quarterly sales of GSK's RSV vaccine dropped more than 70%, following narrower recommendations for who should get the shot.

New guidelines and the timing of COVID vaccinations impacted uptake of Abrysvo this year, according to a company executive.

Additionally, all children younger than two years whose mothers were not immunised during pregnancy will also be eligible for ...

The British pharma’s experience during the third quarter mirrored that of rival Pfizer, which also reported lower sales of ...